<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Quantum Pharmaceuticals &#187; compound libraries</title>
	<atom:link href="http://q-pharm.com/category/compound-libraries/feed/" rel="self" type="application/rss+xml" />
	<link>http://q-pharm.com</link>
	<description>The drug discovery company</description>
	<lastBuildDate>Thu, 05 Aug 2010 15:05:38 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>How drug-like are vendor libraries?</title>
		<link>http://q-pharm.com/2009/10/how-drug-like-are-vendor-libraries/</link>
		<comments>http://q-pharm.com/2009/10/how-drug-like-are-vendor-libraries/#comments</comments>
		<pubDate>Mon, 26 Oct 2009 17:24:24 +0000</pubDate>
		<dc:creator>Peter Fedichev, Quantum CTO</dc:creator>
				<category><![CDATA[compound libraries]]></category>
		<category><![CDATA[druglikeness]]></category>
		<category><![CDATA[mechanism of action exploration]]></category>
		<category><![CDATA[toxicity]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=63</guid>
		<description><![CDATA[We use a few chemical compounds vendors in our drug discovery programs (let us call them &#8220;Provider I&#8221;, &#8220;Provider II&#8221;, and &#8220;Provider III&#8221;). Nowadays chemicals providers normally claim about 1M of drug-like compounds readily available for shipping at a very reasonable cost. A few dozen...


Related posts:<ol><li><a href='http://q-pharm.com/2008/01/drug-likeness-what-do-bioavailability-and-toxicity-properties-tell-us-about-druglikeness/' rel='bookmark' title='Permanent Link: Drug likeness: what do bioavailability and toxicity properties tell us about druglikeness?'>Drug likeness: what do bioavailability and toxicity properties tell us about druglikeness?</a></li>
<li><a href='http://q-pharm.com/2008/05/computer-aided-drug-design-video-from-quantum-pharma/' rel='bookmark' title='Permanent Link: Computer aided drug design video from Quantum Pharma'>Computer aided drug design video from Quantum Pharma</a></li>
<li><a href='http://q-pharm.com/2008/09/from-binding-data-to-pharmacokinetics-a-novel-approach-to-active-drug-absorbtion-prediction/' rel='bookmark' title='Permanent Link: From binding data to pharmacokinetics: a novel approach to active drug absorbtion prediction'>From binding data to pharmacokinetics: a novel approach to active drug absorbtion prediction</a></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2009/10/how-drug-like-are-vendor-libraries/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
